India’s first fully indigenously developed Pneumococcal Polysaccharide Conjugate Vaccine (Pneumonia vaccine) has received the approval from Drug Controller General of India (DCGI). It will be utilized for active immunization against invasive disease and pneumonia caused by “Streptococcus pneumonia” among infants.
Pneumococcal Polysaccharide Conjugate Vaccine (Pneumonia vaccine) has been developed by Serum Institute of India Pvt Ltd, Pune. It is India’s first indigenously developed vaccine in the field of pneumonia. With the DCGI’s approval, Serum Institute of India has been granted permission to manufacture the vaccine domestically.
The Election Commission of India has launched the powerful digital initiative which is the 'Know…
Honorable Union Minister of Science and Technology the Dr. Jitendra Singh has recently inaugurated the…
Recently the Newcastle Disease have spread rapidly the across several European countries and it created…
For the major breakthrough in the AI the Microsoft has introduced the new transcription model…
The Outer Space Treaty is the foundation of the international space law which was signed…
Indian Navy has inducted the its third nuclear-powered ballistic missile submarine which is INS Aridaman.…